Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.269
Filter
1.
Rev. colomb. reumatol ; 28(1): 52-56, ene.-mar. 2021. graf
Article in Spanish | LILACS | ID: biblio-1341360

ABSTRACT

RESUMEN Objetivo: Contextualizar una receta médica de comienzos del siglo XIX en el Nuevo Reino de Granada, en la cual se prescribe el guaco para disminuir síntomas generados por afecciones del sistema músculo-esquelético. De igual forma, analizar, en función de los conocimientos actuales, cómo actúa la fórmula sobre mecanismos fisiopatológicos de la enfermedad, explicando la reducción del dolor y las secuelas asociadas. Material y método: Búsqueda documental en el Archivo Histórico Cipriano Rodríguez Santamaría, de la Biblioteca Octavio Arizmendi Posada, de la Universidad de La Sabana. Se analizó el documento denominado Reumatismo. Posteriormente se realizó una revisión de la literatura entre 1999-2018, en las bases de datos ScienceDirect/ClinicalKey/Scielo. Conclusiones: Existe evidencia científica que podría explicar la efectividad del guaco, usado en el Nuevo Reino de Granada por sus propiedades antiinflamatorias y analgésicas aportadas por componentes como la cumarina y los flavonoides. Sin embargo, una descripción vaga en la posología del guaco, signos, síntomas y comorbilidades que no se mencionan en la receta, dificulta analizar la eficacia del tratamiento y cómo lograba disminuir o controlar específicamente los síntomas dados por afecciones del sistema musculoesquelético con su aplicación. Esta tradición, en consecuencia, carece de sustento propiamente científico para el tratamiento médico de enfermedades osteomusculares.


ABSTRACT Objective: To contextualize a medical prescription of the early 19th century in the New Kingdom of Granada, in which guaco was prescribed to reduce symptoms caused by musculoskeletal system disorders, which were ill-defined at the time. Similarly, based on current knowledge, to analyse the manner in which the formula acts on pathophysiological mechanisms of rheumatic diseases, in order to explain the reduction of pain, and associated sequelae. Material and method: Documentary research into the Cipriano Rodríguez Santamaría Historical Archive of the Octavio Arizmendi Library of the University of La Sabana, in Chía, Colombia. The document analysed was called Rheumatism. Subsequently, a review of the literature was carried out in Science Direct / Clinical Key / Scielo databases in the period from 1999 to 2018. Conclusions: There is scientific evidence that supports the efficiency of guaco used in the Kingdom of New Granada due its anti-inflammatory and analgesic properties. However, a vague description of the dosage of the guaco, signs, symptoms, and comorbidities, which are not mentioned in the prescription, hinders the understanding of its application and the thorough effectiveness of the treatment in order to control the symptoms of musculoskeletal system conditions. This tradition, consequently, lacks proper scientific support for the medical treatment of musculoskeletal disorders.


Subject(s)
Humans , Rheumatic Diseases , Mikania , Musculoskeletal System , Therapeutics , Knowledge
2.
Rev. argent. reumatolg. (En línea) ; 32(1): 7-15, mar. 2021. ilus, tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1279753

ABSTRACT

Con el fin de evaluar el impacto de la infección por SARS-CoV-2 en pacientes con enfermedades reumáticas, la Sociedad Argentina de Reumatología desarrolló el Registro Nacional de Pacientes con Enfermedades Reumáticas y COVID-19 (SAR-COVID). El objetivo del presente trabajo fue evaluar las características sociodemográficas y clínicas de los pacientes con enfermedades reumáticas e infección por SARS-CoV-2 incluidos en el registro SAR-COVID y describir las complicaciones y desenlaces de la COVID-19 en esta población. Material y métodos: SAR-COVID es un registro nacional, multicéntrico y observacional, en el cual se incluyen de manera consecutiva pacientes ≥18 años de edad, con diagnóstico de alguna enfermedad reumática que hayan cursado infección por SARS-CoV-2. Se consignan datos sociodemográficos, comorbilidades, enfermedad reumática y su tratamiento, características clínicas, laboratorio, complicaciones y tratamientos de la infección por SARS-CoV-2. Resultados: Se incluyeron 525 pacientes, con una edad media de 51.3 años (DE 15.2). Las enfermedades reumatológicas más frecuentes fueron artritis reumatoidea (40.4%), lupus eritematoso sistémico (14.9%) y espondiloartritis (8.2%). El 72.9% recibía tratamiento inmunosupresor o inmunomodulador al momento del inicio de la infección y 36.9% glucocorticoides. En la mayoría de los casos, el diagnóstico de infección por SARS-CoV-2 se llevó a cabo mediante RT-PCR (95%), 39.4% en la consulta externa, 32.2% en el departamento de urgencias, y 14.7% durante la hospitalización. La mayoría de los pacientes presentaron síntomas, siendo los más frecuentes fiebre (56.2%), tos (46.7%) y cefalea (39.2%). Durante la infección, 35.1% requirieron hospitalización y 11.6% en unidad de cuidados intensivos. El 75.1% se recuperó completamente, 8.4% presentó secuelas y 6.9% murieron a causa de COVID-19. Conclusión: En este primer reporte del registro SAR-COVID encontramos una amplia distribución de enfermedades reumáticas. La mayoría de los pacientes tuvieron una buena evolución de la infección, sin embargo un 7% falleció como consecuencia de la misma, datos comparables a los reportados por otros registros latinoamericanos con poblaciones similares.


In order to assess the impact of SARS-CoV-2 infection in patients with rheumatic diseases, the Argentine Society of Rheumatology has developed the National Registry of Patients with Rheumatic Diseases and COVID-19 (SAR-COVID). The aim of this study was to evaluate the sociodemographic and clinical characteristics of patients with rheumatic diseases and SARS-CoV-2 infection included in the SAR-COVID registry and to describe the complications and outcomes of COVID-19 in this population. Methods: SAR-COVID is a national, multicenter and observational registry, in which patients ≥18 years of age, with a diagnosis of a rheumatic disease who had SARS-CoV-2 infection are consecutively included. Sociodemographic data, comorbidities, underlying rheumatic disease and treatment, clinical characteristics, complications, laboratory and treatment of the SARS-CoV-2 infection were recorded. Results: A total of 525 patients were included, with a mean age of 51.3 years (SD 15.2). The most frequent rheumatic diseases were rheumatoid arthritis (40.4%), systemic lupus erythematous (14.9%) and spondyloarthritis (8.2%). At the time of the infection, 72.9% were receiving immunosuppressive or immunomodulatory treatment and 36.9% glucocorticoids. Most of the patients were diagnosed using RT-PCR (95%), at outpatient consultation (39.4%), at the emergency room (32.2%) or during hospitalization (14.7%). Symptoms were present in 96% of the patients, the most frequent being fever (56.2%), cough (46.7%) and headache (39.2%). During infection, 35.1% were hospitalized, 11.6% were admitted to the ICU and 6.9% died due to COVID-19. Most of them (75.1%) recovered completely. Conclusions: In this first report of the SAR-COVID registry we found a wide distribution of rheumatic diseases. Most of the patients had a good evolution of the infection, however 7% died as a result of it, comparable to other Latin American registries with similar populations.


Subject(s)
Humans , Arthritis, Rheumatoid , Rheumatology , Rheumatic Diseases , Coronavirus Infections , Betacoronavirus
3.
ABCS health sci ; 46: e021218, 09 fev. 2021. tab
Article in English | LILACS | ID: biblio-1343340

ABSTRACT

INTRODUCTION: Rheumatic diseases have high occurrence in older adults, which may lead to a reduction in independence and quality of life. OBJECTIVE: To calculate prevalence and to identify factors associated with rheumatic diseases in older adults of the urban area of a municipality in Southern Brazil. METHODS: Cross-sectional population-based study, conducted in 2008 in the city of Bagé-RS, Brazil with older adults aged 60 years or over. The outcome was defined from the question "Has any doctor told you that you have rheumatism, arthritis or arthrosis?" Poisson regression was used for the crude and adjusted analysis. RESULTS: A total of 1,593 participants were interviewed. 27.3% (95% CI 25.0-29.5) reported having medical diagnosis of at least one of the rheumatic diseases studied. In the adjusted analysis, it was found that female sex (RP=2.86; 95% CI 2.28-3.59; p≤0.001), without schooling (RP=1.24; 95% CI 1.0-1.58; p=0.047), not living alone (RP=1.29; 95% CI 1.03-1.61; p=0.024), poor self-perception of health (PR=1.54; 95% CI 1.63-2.02; p=0.001), spinal problems (PR=1,96; 95% CI 1.67-2.31; p≤0.001), fall in the last year (PR=1.22; 95% CI 1.04-1.43; p=0.013), incapacity for instrumental activities of daily living (PR=1.20; 95% CI 1.02-1.41; p=0.028) and healthcare appointment in the last 3 months (PR=1.20; 95% CI 1.01-1.42; p=0.035) were associated with the presence of rheumatic diseases (rheumatism, arthritis and arthrosis). CONCLUSION: It is suggested that care of musculoskeletal problems of the spine should be increased, in order to reduce falls and functional disability in older adults, based on actions focused on the prevention of these problems.


INTRODUÇÃO: As doenças reumáticas têm alta ocorrência na população idosa, o que pode levar à redução da independência e da qualidade de vida. OBJETIVO: Determinar a prevalência e identificar os fatores associados às doenças reumáticas em idosos da zona urbana de um município do Sul do Brasil. MÉTODOS: Trata-se de estudo transversal de base populacional, realizado em 2008 na cidade de Bagé-RS, Brasil, com idosos com 60 anos ou mais. O desfecho foi definido a partir da pergunta "Algum médico já disse que você tem reumatismo, artrite ou artrose?" A regressão de Poisson foi usada para a análise bruta e ajustada. RESULTADOS: Foram entrevistados 1.593 idosos. Destes, 27,3% (IC 95% 25,0-29,5) relataram ter diagnóstico médico de pelo menos uma das doenças reumáticas estudadas. Na análise ajustada, constatou-se que o sexo feminino (RP=2,86; IC 95% 2,28-3,59; p≤0,001), sem escolaridade (RP=1,24; IC 95% 1,0-1,58; p=0,047), não vive sozinho (RP=1,29; IC 95% 1,03-1,61; p=0,024), autopercepção de saúde ruim (RP=1,54; IC 95% 1,63-2,02; p=0,001), problemas de coluna (RP=1,96; IC 95% 1,67-2,31; p≤0,001), queda no último ano (RP=1,22; IC 95% 1,04-1,43; p=0,013), presença de incapacidade para atividades instrumentais de vida diária (RP=1,20; IC 95% 1,02-1,41; p=0,028) e consulta médica nos últimos 3 meses (RP=1,20; IC 95% 1,01-1,42; p=0,035) estiveram associados à presença de doenças reumáticas (reumatismo, artrite e artrose). CONCLUSÃO: Sugere-se que os cuidados com os problemas musculoesqueléticos da coluna devem ser aumentados, a fim de reduzir as quedas e a incapacidade funcional em idosos, com base em ações voltadas para a prevenção desses problemas.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Brazil , Rheumatic Diseases/epidemiology , Health of the Elderly , Musculoskeletal Development , Primary Health Care , Cross-Sectional Studies
5.
Actual. osteol ; 17(1): 8-17, 2021. graf, tab
Article in English | LILACS, BINACIS, UNISALUD | ID: biblio-1291888

ABSTRACT

Objective: The main purpose of this study was to evaluate serum 25-hydroxyvitamin D (25OHD) levels and its association with in"ammatory markers in patients with rheumatologic diseases (RD). Methods: A cross-sectional study in 154 women with RD (rheumatoid arthritis, spondyloarthritis and other connective tissue diseases) and 112 healthy individuals as a control group (CG) was carried out. Results: No differences in serum and urine calcium, serum phosphate, and urinary deoxypyridinoline were found. RD group had lower 25OHD and higher PTH compared to CG. RD group had higher C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) compared to CG. The overall mean level of 25OHD (ng/ml) was 26.3±12.0 in the CG and 19.4±6.8 in the RD group (p<0.0001). Moreover, CG had lower percentage of individuals with 25OHD de!ciency compared to RD (29.9% vs 53.2%). The femoral neck BMD was signi!cantly lower in postmenopausal RD women compared to CG. 25OHD levels signi!cantly correlated with ESR and CRP as in"ammatory markers. Age, BMI, presence of RD, and CRP were signi!cantly and negatively associated with 25OHD levels through linear regression analysis. According to univariate logistic regression analysis for 25OHD deficiency (<20 ng/ml), a significant and negative association with BMI, presence of RD, ESR and CRP were found. Conclusion: Patients with RD had lower 25OHD levels than controls and the presence of a RD increases by 2.66 the risk of vitamin D de!ciency. In addition, 25OHD has a negative correlation with ESR and CRP as in"ammatory markers. (AU)


Objetivo El objetivo principal de este estudio fue evaluar los niveles séricos de 25-hidroxivitamina D (25OHD) y su asociación con marcadores inflamatorios en enfermedades reumatológicas. Materiales y métodos: Se realizó un estudio transversal en 154 mujeres con enfermedades reumatológicas (artritis reumatoide, espondiloartritis y otras enfermedades del tejido conectivo) y 112 individuos sanos como grupo control (GC). Resultados: No se encontraron diferencias en el calcio sérico y urinario, el fosfato sérico y la desoxipiridinolina urinaria entre el GC y los sujetos con enfermedades reumatológicas. El grupo de pacientes con enfermedades reumatológicas tenía 25OHD más bajo y PTH más alto en comparación con el GC. Asimismo, el grupo de individuos con enfermedades reumatológicas tenía proteína C reactiva (PCR) y velocidad de eritrosedimentación (VES) más altas en comparación con el GC. El nivel de 25OHD (ng/ml) fue 26,3±12,0 en el GC y 19,4±6,8 en el grupo con enfermedades reumatológicas (p<0,0001). Además, el GC presentó un porcentaje menor de deficiencia de 25OHD en comparación con el grupo con enfermedades reumatológicas (29,9% vs 53,2%). La DMO del cuello femoral fue significativamente menor en las mujeres posmenopáusicas con enfermedades reumatológicas en comparación con el GC. La 25OHD correlacionó significativamente con la VES y la PCR como marcadores inflamatorios. El análisis de regresión lineal mostró que la edad, el IMC, la presencia de una enfermedad reumatológica y la PCR se asociaron significativa y negativamente con los niveles de 25OHD. Mientras que el análisis de regresión logística univariada mostró que la deficiencia de 25OHD (<20 ng/ml), se asoció significativa y negativamente con el IMC, la presencia de una enfermedad reumatológica, la VES y los niveles de PCR. Conclusiones: Los pacientes con enfermedades reumatológicas tenían niveles de 25OHD más bajos que los controles y la presencia de una enfermedad reumatológica aumenta en 2.66 el riesgo de deficiencia de vitamina D. Además, la 25OHD mostró correlación negativa con la VES y la PCR como marcadores inflamatorios. (AU)


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Vitamin D/analogs & derivatives , Vitamin D/blood , Vitamin D Deficiency/etiology , Biomarkers , Rheumatic Diseases/complications , Inflammation/blood , Phosphates/blood , Blood Sedimentation , C-Reactive Protein , Body Mass Index , Bone Density , Logistic Models , Calcium/urine , Calcium/blood , Rheumatic Diseases/blood , Risk , Cross-Sectional Studies , Postmenopause , Amino Acids/urine
6.
Autops. Case Rep ; 11: e2020237, 2021. graf
Article in English | LILACS | ID: biblio-1153177

ABSTRACT

Whipple's Disease, a rare diagnosis caused by the slow-growing bacterium Tropheryma whipplei, most often presents with the classically described signs of malabsorption due to gastrointestinal colonization. However, it can also have signs and symptoms that clinically overlap with rheumatic diseases, potentially resulting in misdiagnosis. Furthermore, treatment with modern potent biologic immunosuppressive agents and classic disease modifying anti-rheumatic drugs (DMARDs) can lead to serious exacerbation of undiagnosed infections. We present the case of a middle-aged woman with long term complaints of arthalgias, who was diagnosed with seronegative rheumatoid arthritis and subsequently treated for almost 7 years with such immunosuppressive therapies. The patient's disease course included chronic diarrhea that abruptly intensified and culminated in fatal hypovolemic shock/sepsis. A diagnosis of WD was made by autopsy examination, wherein several organ systems were found to be heavily involved by Tropheryma whipplei organisms, and their identification was confirmed with histochemical and molecular evaluation. Notably, most bacterial organisms were located deeply in the submucosa/muscularis of affected organs, a practical reminder to practicing pathologists that challenges the classic histopathologic description of Whipple disease as an infiltration of predominantly lamina propria, and the potential for sampling bias in typically superficial endoscopic biopsies during routine procedures.


Subject(s)
Humans , Female , Middle Aged , Actinomycetales Infections/pathology , Tropheryma , Whipple Disease/complications , Whipple Disease/pathology , Autopsy , Rheumatic Diseases/complications , Sepsis/etiology , Diagnostic Errors/prevention & control
7.
Rev. colomb. reumatol ; 27(4): 286-290, oct.-dic. 2020. graf
Article in English | LILACS | ID: biblio-1289332

ABSTRACT

ABSTRACT Cocaine use is associated with several rheumatic syndromes. A series of cases is presented of 10 patients (7 male and 3 female), age at onset: 19-38 years-old. They consulted due to a variety of symptoms: fever, arthritis, swollen hands, stroke, fetal losses, arterial hypertension, alveolar hemorrhage, leucocytoclastic vasculitis, genital bleeding, among others. Half of them showed positive ANA and Ro antibodies, lymphopenia and positive P-ANCA. Treatments with steroids in bolus, cyclophosphamide and rituximab were used, with a good response. This series highlights clinical manifestations at onset that can mimic primary rheumatic diseases. Rheumatologists should consider cocaine use in the differential diagnoses of vasculitis and pseudovasculitis syndromes.


RESUMEN El uso de cocaína se asocia con varios síndromes reumáticos. Se trata de 10 pacientes (7 varones y 3 mujeres) con una edad al inicio del cuadro entre 19-38 anos, quienes consultaron por una variedad de síntomas: fiebre, artritis, tumefacción de manos, accidente isquémico transitorio, pérdidas fetales, hipertensión arterial, hemorragia alveolar, vasculitis leucoci-toclástica y hemorragia genital, entre otros. La mitad de estos pacientes presentaron ANA y anticuerpo anti-Ro positivos, linfopenia y p-ANCA positivo. Fueron tratados con corticoides intravenosos en bolo, ciclofosfamida y rituximab, con buena respuesta. Esta serie resalta las manifestaciones clínicas que, al inicio del cuadro, pueden imitar una enfermedad reumática primaria. Los reumatólogos debieran considerar a la cocaína en el diagnóstico diferencial de las vasculitis y los síndromes seudovasculíticos.


Subject(s)
Humans , Adult , Rheumatology , Signs and Symptoms , Cocaine-Related Disorders , Diagnosis , Rheumatic Diseases
8.
Rev. argent. reumatolg. (En línea) ; 31(4): 44-49, dic. 2020. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1288211

ABSTRACT

Introducción: Las recetas médicas o prescripciones históricas en el territorio de la Nueva Granada (hoy Colombia) revelan la evolución del manejo de la enfermedad en función de los efectos benéficos de administrar algún tipo de agente medicinal de origen vegetal, animal o mineral. Objetivo: Describir el tratamiento del reumatismo en los siglos XVIII y XIX, con base en dos recetas médicas de la época con base en la fundamentación contemporánea de su interacción fisiológica. Materiales y métodos: Búsqueda documental en el archivo Histórico de la Biblioteca Octavio Arizmendi Posada de la Universidad de La Sabana, donde se encontraron las recetas tituladas "Reumatismo" y "Rehumas". Resultados: Se describen cuatro clases de tratamientos para las enfermedades reumáticas utilizados en los siglos XVIII y XIX y orientados principalmente a la disminución del dolor. Este artículo presenta las bases fisiológicas de estos tratamientos, y cómo pudieron o no haber tenido algún efecto calmante al examinar su fisiología. Conclusiones: Estos medicamentos coloniales neogranadinos no ameritan su uso en el contexto actual de la medicina, pero pudieron representar una ayuda terapéutica en su momento.


Introduction: the medical prescriptions or historical prescriptions in the territory of New Granada (present-day Colombia) reveal the evolution of disease management given the beneficial effects of administering some type of medicinal agent of plant, animal or mineral origin. Objective: To describe the treatment of rheumatism in the 18th and 19th centuries based on two medical prescriptions of the time based on the contemporary rationale of their physiological interactions. Materials and methods: Documentary search in the Historical Archive of the Octavio Arizmendi Posada Library at Universidad de La Sabana in Colombia, where the prescriptions entitled "Reumatismo" and "Rehuma" were found. Results: Four classes of treatments for rheumatic diseases used in the 18th and 19th centuries and mainly oriented to pain reduction are described. This article presents the physiological basis of these treatments, and how they may or may not have had some calming effect when examining their physiology. Conclusions: These Neogranadian colonial drugs do not deserve their use in the current context of medicine, but they may have represented a therapeutic aid at the time.


Subject(s)
Rheumatic Diseases , Pain , History of Medicine
9.
Rev. colomb. reumatol ; 27(3): 166-176, jul.-set. 2020. tab, graf
Article in English | LILACS | ID: biblio-1251655

ABSTRACT

A b s t r a c t Purpose: To describe health-related QOL (HRQOL) in patients with musculoskeletal symptoms, compared to a population with other comorbidities, and a healthy population. Methods: A cross-sectional study was carried out on an open population involved in a community-oriented program for control of rheumatic diseases (COPCORD) study in Colombia, using EQ-5D-3L for estimating QOL, and the health assessment questionnaire disability index (HAQ-DI) for functional capacity. Results: Out of the total 4020 individuals evaluated, 2274 had rheumatic diseases, 642 had non-rheumatic diseases, and 1104 were healthy subjects. Spondyloarthritis (SpA) and rheumatoid arthritis (RA) patients had more complaints regarding pain/discomfort and mobility. As for daily activities, the diseases that mostly affected them were systemic lupus erythematosus (SLE) and RA. RA and fibromyalgia (FM) patients had the worst scores as regards anxiety/depression and self-care dimensions. FM patients had the lowest QOL measured by EQ-VAS (57.7 ± 26.2). The most frequent non-rheumatic diseases were cardiovascular and mental disorders, with 20% of these patients having a moderate level of pain/discomfort and anxiety/depression. The rheumatic patients reported a decrease in functional capacity (HAQ: 0.49), in contrast to the healthy population (0.01), and the population having other diseases (0.06). Conclusion: Rheumatic disease patients in Colombia had the worst QOL compared to the healthy population and patients with other comorbidities. Rheumatic patients had greater functional limitations, even more so when having comorbidities. This study revealed potential factors of interest requiring the attention of public health authorities, and for improving patients' QOL.


RESUMEN Objetivo: Describir la calidad de vida relacionada con la salud en pacientes con síntomas musculoesqueléticos, en comparación con pacientes con enfermedades no reumáticas y una población sana. Métodos: Se realizó un estudio transversal en comunidad abierta, en personas involucradas en un programa orientado a la comunidad para el control de enfermedades reumáticas (COP-CORD) en Colombia, utilizando el EQ-5D-3L para estimar la calidad de vida y el cuestionario de evaluación de la salud (HAQ- DI) para la capacidad funcional. Resultados: Se evaluaron 4.020 individuos; 2.274 tenían enfermedades reumáticas, 642 tenían enfermedades no reumáticas y 1.104 eran sujetos sanos. Los pacientes con espondiloartritis (SpA) y artritis reumatoide (AR) tuvieron mayores quejas con respecto al dolor/malestar y la movilidad. En cuanto a las actividades diarias, los enfermos con lupus eritematoso sistémico (LES) y AR fueron los más afectados. Los pacientes con AR y fibromialgia (FM) tuvieron las peores puntuaciones en ansiedad/depresión en las dimensiones de cuidado personal. Los pacientes con FM tuvieron la calidad de vida más baja medida por EQ-VAS (57,7 ± 26,2). Las enfermedades no reumáticas más frecuentes fueron los trastornos cardiovasculares y mentales; el 20% de estos pacientes tenía un nivel moderado de dolor/malestar y ansiedad/depresión. Los pacientes reumáticos reportaron una disminución de la capacidad funcional (HAQ: 0,49); en contraste con la población sana (0,01) y la población con otras enfermedades (0,06). Conclusión: Los pacientes con enfermedades reumáticas en Colombia tuvieron la peor calidad de vida en comparación con la población sana y los pacientes con otras enfermedades. Los pacientes reumáticos tuvieron una mayor limitación funcional, incluso más que los que tenían otras enfermedades. Este estudio reveló posibles factores relacionados con las enfermedades reumáticas que requieren la atención de las autoridades de salud pública con el objetivo de mejorar la calidad de vida de los pacientes.


Subject(s)
Humans , Quality of Life , Rheumatic Diseases , Surveys and Questionnaires , Patients , Activities of Daily Living , Comorbidity , Open Population , Healthy Volunteers
10.
Rev. colomb. reumatol ; 27(3): 230-241, jul.-set. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1251664

ABSTRACT

RESUMEN Objetivo: Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. Materiales y métodos: Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. Resultados: Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. Conclusión: La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19.


ABSTRACT Objective: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. Materials and methods: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. Results: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. Conclusion: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19.


Subject(s)
Humans , Patients , Rheumatic Diseases , COVID-19 , Therapeutics , Delphi Technique , Adult
11.
Rev. cuba. reumatol ; 22(2): e831, mayo.-ago. 2020.
Article in Spanish | LILACS, CUMED | ID: biblio-1126812

ABSTRACT

Introducción: La COVID-19 o enfermedad provocada por el nuevo coronavirus SARS-CoV-2 afecta también a la población pediátrica. Ante el actual brote de la pandemia en Cuba, se han generado muchas inquietudes entre los pacientes que padecen alguna enfermedad reumática de la infancia y sus familiares. Estos niños pueden catalogarse como de riesgo de manera especial. Objetivos: Reflexionar sobre las recomendaciones dadas a los pacientes con enfermedad reumática ante la pandemia de COVID-19 y brindar nuevas recomendaciones adecuadas a nuestro contexto social a los pacientes pediátricos cubanos con enfermedad reumática. Métodos: Revisión documental. Se emplearon motores de búsqueda (Google académico y SciELO-Scientific Electronic Library Online), y se analizaron evidencias científicas, preprints y revisiones narrativas. Se realizaron recomendaciones basadas en estas. Conclusiones: Las recomendaciones ofrecidas, a partir de la revisión realizada, se han adaptado al contexto social del paciente pediátrico cubano con enfermedad reumática. También se ha hecho referencia a las medidas tomadas por nuestro gobierno y los diferentes ministerios, así como a sitios oficiales de información, y que tienen validez para los ciudadanos cubanos. Se insiste en que cualquier manejo, medida o sugerencia ante la COVID-19 se debe personalizar a cada paciente y grupo de pacientes en cuestión, por región, país y provincia, de acuerdo con el entorno propio y la enfermedad de base(AU)


Introduction: The COVID-19 or disease caused by the new SARS-CoV-2 coronavirus, in its transmission does not distinguish age, and the pediatric population may also be affected. Given the current outbreak of the pandemic in our country, there have been several concerns that have been generated among patients and their families who suffer from a childhood rheumatic disease and that can be classified as at risk in a special way. Objectives: To reflect on the recommendations given to patients with rheumatism due to the SARS-Cov-2 coronavirus pandemic and to offer our own recommendations to Cuban pediatric patients with rheumatic disease already appropriate to our social context. Methods: Documentary review. Search engines (Google academic and SciELO-Scientific Electronic Library Online) were used, and scientific evidence, preprints and narrative reviews were analyzed, recommendations based on them were made. Conclusions: The recommendations given by the authors based on the review carried out have been adapted to the social context of the Cuban pediatric patient with rheumatic disease. Thus, reference has also been made to measures taken by our government and the different ministries, to official information sites, which are understood and have validity for Cuban citizens. Any handling, measure or suggestion before the COVID-19 must be personalized to each patient and group of patients in question, by region, country, province, according to their own environment(AU)


Subject(s)
Humans , Child , World Health Organization , Rheumatic Diseases/complications , Coronavirus Infections/complications
13.
Rev. Assoc. Med. Bras. (1992) ; 66(8): 1093-1099, Aug. 2020. tab
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1136344

ABSTRACT

SUMMARY AIM To describe the prevalence of dyslipidemia in children and adolescents with autoimmune rheumatic diseases (ARDs), particularly juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (jSLE), and juvenile dermatomyositis (JDM). METHODS Retrospective cross-sectional study conducted in the pediatric rheumatology outpatient clinic. We evaluated 186 children and adolescents between the ages of 5 and 19 years. The medical records were reviewed for the following data: demographic and clinical features, disease activity, and lipid profile (triglycerides (TG), total cholesterol (TC), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) and very low density lipoprotein (VLDL-C)). In addition, non-HDL cholesterol was calculated as TC minus HDL-C. The cut-off points proposed by the American Academy of Pediatrics were used to classify the lipid profile. RESULTS Dyslipidemia was observed in 128 patients (68.8%), the most common being decreased HDL-C (74 patients, 39.8%). In the JIA group there was an association between the systemic subtype and altered LDL-C and NHDL-C, which demonstrated a more atherogenic profile in this subtype (p=0.027 and p=0.017, respectively). Among patients with jSLE, the cumulative corticosteroid dose was associated with an increase in LDL-C (p=0.013) and with a decrease in HDL-C (p=0.022). CONCLUSION Dyslipidemia is common in children and adolescents with ARDs, especially JIA, jSLE, and JDM, and the main alteration in the lipid profile of these patients was decreased HDL-C.


RESUMO OBJETIVO Descrever a prevalência de dislipidemias em crianças e adolescentes com doenças reumáticas autoimunes (Drai), em particular artrite idiopática juvenil (AIJ), lúpus eritematoso sistêmico juvenil (Lesj) e dermatomiosite juvenil (DMJ). MÉTODOS Estudo transversal retrospectivo realizado no ambulatório de reumatologia pediátrica. Foram avaliados 186 crianças e adolescentes com idades entre 5 e 19 anos. Foram coletados dos prontuários dados demográficos, clínicos, atividade de doença e perfil lipídico (triglicérides (TG), colesterol total (CT) e frações LDL-c (low density lipoprotein); HDL-c (high density lipoprotein) e VLDL-c (very low density lipoprotein). Foi também calculada a fração não HDL do colesterol (CT-NHDL -c). Para classificação do perfil lipídico, foram adotados os pontos de corte propostos pela American Academy of Pediatrics. RESULTADOS A dislipidemia foi observada em 128 pacientes (68,8%), sendo a mais comum a diminuição do HDL-c em 74 (39,8%). No grupo AIJ houve uma associação entre o subtipo sistêmico com alteração de LDL-c e NHDL-c, mostrando um perfil mais aterogênico neste subtipo (p=0,027 e 0,017, respectivamente). Em relação aos pacientes com Lesj, podemos observar que a dose cumulativa de CTC teve associação com o aumento do LDL-c (p=0,013) e com a diminuição do HDL-c (p=0,022). CONCLUSÃO A dislipidemia é frequente em crianças e adolescentes com Drai, em especial, AIJ, Lesj e DMJ, e a principal alteração no perfil lipídico desses pacientes foi a diminuição do HDL-c.


Subject(s)
Humans , Male , Child, Preschool , Child , Adolescent , Young Adult , Rheumatic Diseases , Dyslipidemias , Chronic Disease , Cross-Sectional Studies , Retrospective Studies , Lipids
14.
Rev. cuba. reumatol ; 22(1): e111, ene.-abr. 2020.
Article in Spanish | LILACS, CUMED | ID: biblio-1126799

ABSTRACT

Introducción: Los pacientes mayores de 65 años son la parte de la población más afectada por las enfermedades reumáticas. El diagnóstico reumatológico en los ancianos se complica por las manifestaciones clínicas que imitan los cambios relacionados con la edad. Objetivo: Sintetizar los aspectos generales del manejo clínico, el diagnóstico y la terapéutica de las principales enfermedades reumáticas inflamatorias y no inflamatorias en este subgrupo de población. Desarrollo: Los principales trastornos musculoesqueléticos no inflamatorios que afectan a los adultos mayores son la osteoartritis, la osteoporosis y el dolor de espalda, mientras que las artritis inflamatorias predominantes comprenden la artritis reumatoide, la artropatía cristalina, la polimialgia reumática y las formas inflamatorias de la osteoartritis. Conclusiones: Para el diagnóstico y la terapéutica de las principales enfermedades reumáticas (inflamatorias y no inflamatorias) en este subgrupo de población, es necesario el enfoque multidisciplinar(AU)


Introduction: It is recognized that patients older than 65 years are the part of the population most affected by rheumatic diseases. The rheumatological diagnosis in the elderly is complicated by clinical manifestations, which mimic the changes related to age. Objective: To synthesize the general aspects of clinical management, diagnosis and therapy of the main rheumatic diseases inflammatory and non-inflammatory in this subgroup of the population. Development: The main non-inflammatory musculoskeletal disorders that affect older adults are osteoarthritis, osteoporosis and back pain, while the predominant inflammatory arthritis include rheumatoid arthritis, crystalline arthropathy, polymyalgia rheumatica and the inflammatory forms of osteoarthritis. Conclusions: It is vital for academics to be involved in the rheumatological aspects of aging and call attention to the imperative that is to promote reflective discussion within community medicine to address the impact of musculoskeletal problems that affect function and mobility of the elderly and immune dysregulation in aging, among other issues(AU)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Osteoarthritis/epidemiology , Polymyalgia Rheumatica , Arthritis, Rheumatoid/drug therapy , Rheumatic Diseases/diagnosis , Crystal Arthropathies , Osteoporosis/epidemiology , Arthritis, Rheumatoid/therapy , Back Pain
15.
Rev. cuba. reumatol ; 22(1): e107, ene.-abr. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1126796

ABSTRACT

Introducción: Las enfermedades reumáticas son un grupo de alrededor de 250 enfermedades que se caracterizan por afectar fundamentalmente el sistema osteomioarticular. En su mayoría se consideran enfermedades sistémicas, ya que pueden afectar cualquier órgano o sistema de órganos del cuerpo humano. Una de las complicaciones más graves es el daño al sistema cardiovascular. Objetivo: Describir el comportamiento de los factores de riesgo de afectación cardiovascular en los pacientes con enfermedades reumáticas. Método: Se realizó un estudio descriptivo, de corte transversal, en 87 pacientes con diagnóstico de distintas enfermedades reumáticas. Para el diagnóstico positivo se tuvieron en cuenta los criterios del American College of Rheumatology. Se aplicó un cuestionario creado específicamente para la investigación; se realizaron exámenes complementarios; se determinaron medidas antropométricas; y se revisaron las historias clínicas para comprobar los factores de riesgo cardiovascular. Se empleó el índice de correlación de Pearson para determinar la correlación entre las variables del estudio. Resultados: El promedio de edad de la muestra de estudio fue de 57,82 años, con predominio de pacientes con artritis reumatoide (63,33 por ciento) y tiempo de evolución entre 1 y 5 años (59,77 por ciento). Solo el 25,29 por ciento presentaba normopeso y el 28,74 por ciento tenía daño cardiovascular. Conclusiones: Las enfermedades reumáticas constituyen por sí solas un factor de riesgo de daño cardiovascular; el tiempo de evolución de la enfermedad y las alteraciones del estado nutricional son los elementos que mayor incidencia tienen en la afectación cardiovascular de estos pacientes.


Introduction: Rheumatic diseases are a group of around 250 diseases that are characterized by fundamentally affecting the osteomyoarticular system. Most of them are considered as systemic diseases because they can affect any organ or organ system of the human body. Cardiovascular damage is one of the most frequent complications among rheumatic diseases patients. Objective: To describe risk factor's behavior of cardiovascular affectation in patients with rheumatic diseases. Methods: A descriptive, cross-sectional study was carried out in 87 patients diagnosed with different rheumatic diseases. For the positive diagnosis, the criteria of the American College of Rheumatology were taken into account. A questionnaire created specifically for the research was applied, complementary tests were carried out, anthropometric measures were determined and the clinical history was reviewed to determine the cardiovascular risk factors. The Pearson correlation index was used to determine correlation among the study variables. Results: The average age of studied patients was 57.82 years old, with predominance of patients with rheumatoid arthritis (63.22 percent) and time evolution between 1 and 5 years (59.77 percent). Only 25.29 percent had normal weight and 28.74 percent presented cardiovascular damage. Conclusions: Rheumatic diseases are by themselves a risk factor for cardiovascular damage; the time of evolution of the disease and the alterations of the nutritional status are the elements that have the highest incidence on the presence of cardiovascular affectation(AU)


Subject(s)
Humans , Arthritis, Rheumatoid/prevention & control , Cardiovascular Diseases/complications , Rheumatic Diseases/complications , Nutritional Status , Heart Disease Risk Factors , Epidemiology, Descriptive , Cross-Sectional Studies , Risk Factors , Ecuador
16.
Rev. méd. Chile ; 148(3): 320-326, mar. 2020. tab
Article in Spanish | LILACS | ID: biblio-1115795

ABSTRACT

Background: The presence of multiple lymphadenopathies can be a diagnostic challenge. Aim: To describe the clinical, laboratory and imaging characteristics of 19 patients with lymphadenopathies of rheumatologic origin. Material and Methods: Review of medical records of 19 patients aged 16 to 72 years (68%) with lymphadenopathies presumably secondary to a rheumatic disease. Results: Six patients had systemic lupus erythematosus, six had Sjogren's disease, three had sarcoidosis, two had rheumatoid arthritis, one had IgG4 related disease and one had mixed connective tissue disease. A lymph node biopsy was performed in 11 patients and in eight a lymphoid follicular hyperplasia was found. Systemic symptoms were reported by 68% of patients. Blood lactate dehydrogenase was elevated only in cases associated with hemolytic anemia. There was no specific or predictable localization of the lymphadenopathies in imaging studies, except in the cases of sarcoidosis. The average size of the lymphadenopathies was 13.5 mm in diameter in short axis and there was no presence of necrosis, calcification, or conglomerate formation. Only one case presented splenomegaly. All patients responded favorably to corticosteroids. Conclusions: Lymphadenopathies associated with rheumatologic diseases can occur in a wide variety of diseases, especially systemic lupus erythematosus and Sjögren's disease. The absence of LDH elevation and splenomegaly and the absence of imaging findings such as conglomerates can orient to a rheumatologic origin.


Subject(s)
Humans , Adolescent , Adult , Middle Aged , Aged , Young Adult , Rheumatic Diseases , Lymphadenopathy
17.
Rev. cuba. reumatol ; 22(supl.1): e843, tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1280397

ABSTRACT

Las gammapatías monoclonales son un grupo amplio de enfermedades de células hematológicas con expresión clínica variable, con afectación sistémica o localizada. Muchos de estos trastornos simulan enfermedades reumáticas, y pueden presentarse previa- o posteriormente a la enfermedad de base, por lo cual dificultan su diagnóstico. El propósito de este estudio es comunicar los casos de cinco pacientes con manifestaciones clínicas de enfermedades reumáticas y diagnóstico final de enfermedades oncohematológicas. Se realizó un estudio descriptivo transversal mediante el análisis de historias clínicas de pacientes evaluados en el Servicio de Reumatología del Hospital José María Cullen de Santa Fe entre marzo del 2010 y junio del 2019. Se incluyó a cinco pacientes que fueron estudiados por sospecha de enfermedad reumatológica hasta llegar al diagnóstico final de gammapatía monoclonal. Cuatro pacientes presentaron mieloma múltiple manifestado como síndrome de Schnitzler; xantogranuloma del adulto y amiloidosis; aplastamientos vertebrales múltiples; falla renal aguda, respectivamente. El quinto paciente se presentó simulando una vasculitis sistémica con afectación multiorgánica y diagnóstico final de linfoma intravascular. Los pacientes fueron derivados al Servicio de Oncología y Hematología para su atención. A partir de la serie de casos analizados, se concluye que las manifestaciones reumáticas de las enfermedades oncohematológicas se deben tener presentes en el accionar diario para evitar la demora diagnóstica y los tratamientos innecesarios(AU)


Monoclonal gammapathies are a broad group of diseases from hematopoietic cells with variable clinical features and systemic or limited involvement. These entities could begin as a rheumatic disease, even previously to the diagnosis of MG. To describe five patients with rheumatic manifestations that lately were diagnosed as monoclonal gammapathies. We describe the more relevant features of five patients assisted in our rheumatology center. Four patients were diagnosed with multiple myeloma that begins as: 1) Schnitzler's syndrome, 2) Adult-onset xanthogranuloma and amyloidosis, 3) multiple vertebral fracture, 4) acute kidney failure. The 5th patient has a vasculitis-like syndrome due to an intravascular lymphoma. The rheumatic-like syndromes are infrequent but we should take into account this diagnosis in our clinical practice for rapid diagnostic and correct treatment(AU)


Subject(s)
Humans , Rheumatic Diseases , Hematology , Medical Oncology , Paraproteinemias/diagnosis , Epidemiology, Descriptive , Cross-Sectional Studies
18.
Rev. cuba. reumatol ; 22(supl.1): e859, tab
Article in Spanish | LILACS, CUMED | ID: biblio-1280387

ABSTRACT

Introducción: La enfermedad cardiovascular es un problema frecuente en pacientes con trastornos reumáticos sistémicos. Los pacientes pueden padecer una enfermedad asociada a afección cardiaca en el momento del diagnóstico o en una fase posterior del curso de la enfermedad reumática. Objetivo: Determinar las variables que se involucran en la enfermedad coronaria en pacientes reumáticos. Métodos: Se realizó una investigación estadístico-inferencial a partir de una variable dicotómica con variables medidas en escalas de razón y cualitativas, y el modelo de regresión logística binaria. Durante un periodo de 2 años se atendieron en consulta a 105 pacientes reumáticos del Instituto Ecuatoriano de Seguridad Social, interconsultados en cardiología. Al tratarse de una población no muy numerosa (105 pacientes), pues esta consulta se hizo solamente una vez cada seis meses, por un especio de 5 horas. Se estudiaron los factores más representativos como edad, género, peso en libras, estatura en centímetros, ingresos en dólares y el estado civil. Resultados: La tabla permitió evaluar el ajuste del modelo de regresión (hasta este momento, con un solo parámetro en la ecuación), comparando los valores predichos con los valores observados. El modelo tuvo una especificidad alta (96,2 por ciento) y una sensibilidad baja (10,3 por ciento). La ecuación logística permitió determinar si un paciente que cumplía con las características de ingresos, edad, peso y estatura determinadas, se podría considerar en el grupo que, a priori, podría padecer de enfermedad coronaria o no. El paciente evaluado con las características descritas, tuvo un 99,99 por ciento de probabilidad de padecer la enfermedad coronaria. Conclusiones: A través de una ecuación logística se logró determinar si un paciente que cumple con las características de edad e ingresos determinados, se podría considerar en el grupo que, a priori, podría padecer de enfermedad coronaria o no(AU)


Introduction: Cardiovascular disease is a frequent problem in patients with systemic rheumatic disorders. Patients may present with disease associated with heart disease at the time of diagnosis or at a later stage in the course of rheumatic disease. Objective: In the present investigation, the main objective is to determine the variables that are involved in the coronary heart disease process in rheumatic patients and the most representative factors such as: age, gender, weight in pounds, height in centimeters, income in dollars and the marital status in a group of rheumatic patients over a period of two years, treated in consultation with the Ecuadorian Social Security Institute. Methods: During a two-year period, a group of rheumatic patients from the IESS were consulted, consulted in a specialized cardiology consultation. Being a not very large population (105 patients), since this consultation was made only once every six months, for a period of 5 hours. Results: The table allows evaluating the fit of the regression model (until now, with a single parameter in the equation), comparing the predicted values with the observed values. Conclusions: Through a logistic equation, it was possible to determine if a patient who meets the characteristics of age and income determined, could be considered in the group that, a priori, could have coronary heart disease or not(AU)


Subject(s)
Humans , Cardiovascular Diseases , Rheumatic Diseases/complications , Coronary Disease/complications , Weights and Measures , Logistic Models , Probability
19.
Rev. chil. reumatol ; 36(2): 54-60, 2020. tab
Article in Spanish | LILACS | ID: biblio-1282387

ABSTRACT

Las terapias biológicas son una herramienta terapéutica fundamental en cierto grupo de pacientes, sin embargo, su seguridad en el embarazo y lactancia no está aún dilucidada. El objetivo de esta revisión es actualizar los conocimientos y recomendaciones respecto al uso de fármacos biológicos durante el embarazo y lactancia. En relación al embarazo, las recomendaciones actuales sugieren que los anti TNF se podrían continuar o mantener hasta el segundo trimestre del embarazo. La terapia anti CD20 (Rituximab) y otros biológicos se recomiendan suspender en el embarazo. Durante la lactancia, se puede iniciar o continuar cualquier terapia biológica. En la primera mitad del embarazo se pueden utilizar algunos biológicos con relativo buen perfil de seguridad y en la lactancia la evidencia sugiere que no producirían mayor riesgo en el niño. Sería ideal contar con estudios randomizados controlados, pero esto podría generar un dilema ético.


Biological therapies are a fundamental therapeutic tool in a certain group of patients. However, the safety of these drugs during pregnancy and lactation remains unclear. Current recommendations regarding anti TNF use during pregnancy suggest these could be maintained until the second trimester of pregnancy. Anti CD20 therapy (Rituximab) and other biologics should not be used in pregnancy. Patients can safely initiate or continue to use biological therapy during lactation. Some biologicals are relatively safe to use during pregnancy and recent studies show that they can be used during lactation without being a major threat to the child. It would be ideal to have randomized controlled studies, but this could create an ethical dilemma.


Subject(s)
Humans , Female , Pregnancy , Biological Therapy , Lactation , Rheumatic Diseases/drug therapy , Tumor Necrosis Factor-alpha/therapeutic use , Biological Products/therapeutic use , Antirheumatic Agents/therapeutic use
20.
Rev. chil. reumatol ; 36(2): 61-68, 2020. tab
Article in Spanish | LILACS | ID: biblio-1282429

ABSTRACT

La actual pandemia COVID 19 ha sido dramática, por su capacidad de contagio y mortalidad. Esta circunstancia necesita del cuidado mantenido, inherente al ser humano por su vulnerabilidad. La medicina representa la forma más humanitaria del cuidado. Quienes la ejercen deben tener una formación continua, que conjugue ciencia y técnica con ética y humanismo, y ser capaz de una comunicación veraz hacia quien demanda ayuda. La reumatología ha debido también enfrentar esta pandemia. Siendo eminentemente clínica, ha visto obstaculizado el encuentro presencial, por potenciales riesgos para médico y paciente. La telemedicina aparece como opción. Sin embargo, más allá de permitir, en esta contingencia, un mejor control y apoyo al paciente, existe reserva que en tiempos normales reemplace a un encuentro presencial. Si bien permite la comunicación con el paciente, carece del examen físico, fundamental en reumatología, que posibilita explorar en forma amplia la corporalidad del paciente como un todo.


The current COVID 19 pandemic has been dramatic, due to its contagion and mortality capacity. This circumstance needs the maintained care, inherent to the human being due to his vulnerability. Medicine represents the most humane form of care. Those who exercise it must have continuous training, which combines science and technique with ethics and humanism, and be capable of truthful communication towards those who demand help. Rheumatology has also had to face this pandemic. Being eminently clinical, it has been hampered the face-to-face meeting, by potential risks for doctor and patient. Telemedicine appears as an option. However, beyond allowing, in this contingency, better control and support for the patient, there is a reservation that in normal times it will replace a face-to-face meeting. Although it allows communication with the patient, it lacks the physical examination, fundamental in rheumatology, which makes it possible to explore the patient's whole body as a whole.


Subject(s)
Humans , Rheumatic Diseases/therapy , Telemedicine , Patient-Centered Care , Pandemics , COVID-19 , Rheumatology , Ethics, Medical
SELECTION OF CITATIONS
SEARCH DETAIL